Paclitaxel loaded poly(L-lactic acid) microspheres: Properties of microspheres made with low molecular weight polymers

International Journal of Pharmaceutics

Volumn 222, Issue 1, 2001, Pages 19-33

  Liggins, Richard T ^a   Burt, Helen M ^b  

^a Angiotech Pharmaceuticals Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLASS; LACTIC ACID; MICROSPHERE; OCTADECANOL; PACLITAXEL; POLYLACTIC ACID; POLYMER;

ARTICLE; COMPARTMENT MODEL; DRUG DIFFUSION; DRUG RELEASE; ENTHALPY; IN VITRO STUDY; MELTING POINT; MOLECULAR SIZE; MOLECULAR WEIGHT; PHASE TRANSITION; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMISTRY, PHARMACEUTICAL; LACTIC ACID; MICROSPHERES; MOLECULAR WEIGHT; PACLITAXEL; POLYMERS;

EID: 0035800238     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00690-1     Document Type: Article

References (32)

1. In vivo controlled release of a luteinizing hormone-releasing hormone agonist from poly(DL-lactic acid) formulations of varying degradation pattern
2. The effect of the addition of low molecular weight poly(DL-lactide) on drug release from biodegradable poly(DL-lactide) drug delivery systems
3. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly(d,l-lactic acid)
4. Control of drug release rates through the use of mixtures of polycaprolactone and cellulose propionate polymers
5. Thermal properties and physical ageing of poly(L-lactic acid)
6. The development of a novel intraperitoneal tumor-seeding prophylactic
7. The glassy state and the glass transition
8. Physico-mechanical properties of degradable polymers used in medical applications: A comparative study
9. Biodegradable polymers for use in surgery - Polyglycolic poly(lactic acid) homo- and copolymers: 1
10. Control of the biodegradation rate of poly(DL-lactide) microparticles intended as chemoembolization materials
11. Synthesis and hydrolytic degradation behaviour of high-molecular-weight L-lactide and glycolide copolymers
12. Factors influencing the profiles of TRH release from copoly(d,l-lactic/glycolic acid) microspheres
13. Controlled cisplatin delivery system using poly(DL-lactic acid)
14. Microencapsulation using poly(L-lactic acid). IV. Release properties of microcapsules containing phenobarbitone
15. Thermal characterization of polylactides
16. Viscosity and glass temperature relations for polymer-diluent systems
17. Some determinants of morphology and release rates from poly(L)lactic acid microspheres
18. Kinetics of drug release from poly(lactic acid)-hydrocortisone microcapsules
19. Solid state characterization of paclitaxel
20. Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill
21. The crystalline state
22. Poly(L-lactic acid) microspheres containing neutron-activatable holium-165: A study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor
23. The influence of polymer glass transition temperature and molecular weight on drug release tablets containing poly(DL-lactic acid)
24. Polylactide. II. Viscosity-molecular weight relationships and unperturbed chain dimensions
25. Aliphatic polyesters. III. Molecular weight and molecular weight distribution in alcohol-initiated polymerization of ε-caprolactone
26. Microencapsulation of progesterone for contraception by intracervical injecton
27. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent
28. In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres
29. A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents